U.S. Department of Health & Human Services Divider Arrow National Institutes of Health Divider Arrow NCATS
This repository is under review for potential modification in compliance with Administration directives.

Showing 1 - 10 of 19 results

Status:
US Approved Rx (2010)
First approved in 2001

Class (Stereo):
CHEMICAL (ABSOLUTE)



Bimatoprost (marketed in the US, Canada and Europe by Allergan, under the trade name Lumigan) ophthalmic solution is a topical medication used for controlling the progression of glaucoma or ocular hypertension, by reducing intraocular pressure. It is...
Status:
US Approved Rx (2012)
First approved in 1996

Class (Stereo):
CHEMICAL (ABSOLUTE)



Cidofovir is an antiviral nucleotide analogue with significant activity against cytomegalovirus (CMV) and other herpesviruses. Cidofovir suppresses cytomegalovirus (CMV) replication by selective inhibition of viral DNA synthesis. Biochemical data sup...
Status:
US Approved Rx (2016)
First approved in 1989

Class (Stereo):
CHEMICAL (ACHIRAL)



Ganciclovir is a synthetic acyclic nucleoside analogue of 2'-deoxyguanosine active against cytomegalovirus. Ganciclovir has been shown to be active against cytomegalovirus (CMV) and herpes simplex virus (HSV) in humans. To achieve anti-CMV activity, ...
Status:
US Approved Rx (2024)
First approved in 1983

Class (Stereo):
CHEMICAL (ABSOLUTE)



Cyclosporins are cyclic polypeptide macrolides that were originally derived from the soil fungus Tolypocladium inflatum. Cyclosporine (also known as cyclosporine A) was discovered by Sandoz and developed for the tretment of immune disorders. The drug...
Status:
US Approved Rx (2018)
First approved in 1958

Class (Stereo):
CHEMICAL (ABSOLUTE)



Dexamethasone is an anti-inflammatory agent that is FDA approved for the treatment of many conditions, including rheumatic problems, a number of skin diseases, severe allergies, asthma, chronic obstructive lung disease, croup, brain swelling and othe...
mixture
Status:
US Approved Rx (2000)
First approved in 2000

Class:
MIXTURE



Verteporfin (trade name Visudyne), a benzoporphyrin derivative, is a medication used for the treatment of patients with predominantly classic subfoveal choroidal neovascularization due to age-related macular degeneration, pathologic myopia or presume...
Status:
US Approved Rx (2012)
First approved in 2012

Class:
PROTEIN

Status:
US Approved Rx (2024)
First approved in 2011

Class:
PROTEIN

Status:
US Approved Rx (2021)
First approved in 2006

Class:
PROTEIN

nucleic acid
Status:
US Previously Marketed
First approved in 2004

Class:
NUCLEIC ACID


Pegaptanib is a selective vascular endothelial growth factor (VEGF) antagonist indicated for the treatment of neovascular (wet) age-related macular degeneration. Pegaptanib is an aptamer, a pegylated modified single-stranded oligonucleotide, which ad...

Showing 1 - 10 of 19 results